IL2RG and T-B+ severe combined immunodeficiency due to gamma chain deficiency: In this study, we employed two genome editing technologies, CRISPR/Cas9 and prime editing, to target the IL2RG c.458T>C mutation in the mosaic T cells of atypical X-SCID patients.